Tower Research Capital (TRC)’s Streamline Health Solutions STRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-828
| Closed | -$4.3K | – | 5615 |
|
|
2025
Q2 | $4.3K | Sell |
828
-504
| -38% | -$1.74K | ﹤0.01% | 4345 |
|
|
2025
Q1 | $3.73K | Buy |
1,332
+272
| +26% | +$974 | ﹤0.01% | 4361 |
|
|
2024
Q4 | $3.99K | Sell |
1,060
-106
| -9% | -$299 | ﹤0.01% | 4552 |
|
|
2024
Q3 | $4.02K | Sell |
1,166
-276
| -19% | -$1.81K | ﹤0.01% | 4705 |
|
|
2024
Q2 | $9.97K | Buy |
1,442
+498
| +53% | +$2.95K | ﹤0.01% | 4189 |
|
|
2024
Q1 | $6.79K | Sell |
944
-360
| -28% | -$2.49K | ﹤0.01% | 4315 |
|
|
2023
Q4 | $8.31K | Buy |
1,304
+1,082
| +487% | +$6.89K | ﹤0.01% | 4523 |
|
|
2023
Q3 | $3.23K | Sell |
222
-194
| -47% | -$3.37K | ﹤0.01% | 5036 |
|
|
2023
Q2 | $7.93K | Sell |
416
-113
| -21% | -$2.72K | ﹤0.01% | 4502 |
|
|
2023
Q1 | $14K | Buy |
529
+193
| +57% | +$5.48K | ﹤0.01% | 3917 |
|
|
2022
Q4 | $8K | Buy |
336
+17
| +5% | +$414 | ﹤0.01% | 4454 |
|
|
2022
Q3 | $6K | Buy |
319
+178
| +126% | +$4K | ﹤0.01% | 5053 |
|
|
2022
Q2 | $3K | Buy |
141
+68
| +93% | +$1.37K | ﹤0.01% | 5408 |
|
|
2022
Q1 | $2K | Sell |
73
-712
| -91% | -$15.3K | ﹤0.01% | 5598 |
|
|
2021
Q4 | $17K | Buy |
785
+165
| +27% | +$3.96K | ﹤0.01% | 3866 |
|
|
2021
Q3 | $17K | Buy |
620
+573
| +1,219% | +$14.2K | ﹤0.01% | 3881 |
|
|
2021
Q2 | $1K | Buy |
+47
| New | +$1.4K | ﹤0.01% | 5261 |
|
|
2021
Q1 | – | Sell |
-576
| Closed | -$13K | – | 5708 |
|
|
2020
Q4 | $13K | Buy |
576
+79
| +16% | +$1.83K | ﹤0.01% | 4164 |
|
|
2020
Q3 | $12K | Buy |
497
+403
| +429% | +$8.43K | ﹤0.01% | 4032 |
|
|
2020
Q2 | $2K | Buy |
94
+50
| +114% | +$742 | ﹤0.01% | 4538 |
|
|
2020
Q1 | $1K | Buy |
+44
| New | +$756 | ﹤0.01% | 2845 |
|
|
2019
Q3 | – | Sell |
-16
| Closed | – | – | 4495 |
|
|
2019
Q2 | $0 | Buy |
16
+13
| +433% | +$250 | ﹤0.01% | 4258 |
|
|
2019
Q1 | $0 | Buy |
+3
| New | +$50 | ﹤0.01% | 4256 |
|
|
2018
Q4 | – | Sell |
-149
| Closed | -$3K | – | 4327 |
|
|
2018
Q3 | $3K | Buy |
+149
| New | +$2.85K | ﹤0.01% | 3335 |
|
|
2017
Q1 | – | Sell |
-116
| Closed | -$2K | – | 3871 |
|
|
2016
Q4 | $2K | Sell |
116
-151
| -57% | -$3.78K | ﹤0.01% | 3459 |
|
|
2016
Q3 | $7K | Sell |
267
-247
| -48% | -$5.55K | ﹤0.01% | 2348 |
|
|
2016
Q2 | $9K | Sell |
514
-156
| -23% | -$3.02K | ﹤0.01% | 2940 |
|
|
2016
Q1 | $14K | Buy |
670
+668
| +33,400% | +$15.1K | ﹤0.01% | 1641 |
|
|
2015
Q4 | $0 | Buy |
+2
| New | +$54 | ﹤0.01% | 5022 |
|
|
2015
Q3 | – | Sell |
-20
| Closed | -$1K | – | 4721 |
|
|
2015
Q2 | $1K | Sell |
20
-20
| -50% | -$755 | ﹤0.01% | 4068 |
|
|
2015
Q1 | $2K | Sell |
40
-14
| -26% | -$844 | ﹤0.01% | 3821 |
|
|
2014
Q4 | $4K | Buy |
54
+37
| +218% | +$2.19K | ﹤0.01% | 2921 |
|
|
2014
Q3 | $1K | Sell |
17
-15
| -47% | -$1.05K | ﹤0.01% | 4150 |
|
|
2014
Q2 | $2K | Buy |
32
+12
| +60% | +$890 | ﹤0.01% | 3458 |
|
|
2014
Q1 | $2K | Buy |
+20
| New | +$1.86K | ﹤0.01% | 3908 |
|
|
2013
Q4 | – | Sell |
-53
| Closed | -$6K | – | 4906 |
|
|
2013
Q3 | $6K | Buy |
+53
| New | +$5.79K | ﹤0.01% | 3568 |
|
Other funds holding STRM
Tower Research Capital (TRC)'s STRM Position: Q3 2025 in Review
Tower Research Capital (TRC) sold out of Streamline Health Solutions (STRM) in Q3 2025, closing a stake of 828 shares — an estimated $4.3K sold.
Tower Research Capital (TRC) first reported a position in STRM in Q3 2013 and held it in 36 quarters. The position peaked at $17K in Q4 2021. 1 fund tracked by Wall St. Rank holds STRM as of Q3 2025.
- Tower Research Capital (TRC) reported no remaining Streamline Health Solutions position as of Q3 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 828 Streamline Health Solutions shares in Q3 2025, an estimated $4.3K.
- Tower Research Capital (TRC) first reported a position in Streamline Health Solutions in Q3 2013 and held it in 36 quarters.
- Tower Research Capital (TRC)'s Streamline Health Solutions position peaked at $17K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Streamline Health Solutions as of Q3 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.